Literature DB >> 20526721

Hypoxia and metabolic phenotypes during breast carcinogenesis: expression of HIF-1alpha, GLUT1, and CAIX.

Chi-Long Chen1, Jan-Show Chu, Wu-Chou Su, Soon-Cen Huang, Wen-Ying Lee.   

Abstract

Hypoxia and acidosis are microenvironmental selection forces during somatic evolution in breast carcinogenesis. The effect of cobalt chloride (CoCl(2))-induced hypoxia on the expression of hypoxia-inducible factor (HIF)-1alpha, glucose transporter 1 (GLUT1), and carbonic anhydrase IX (CAIX) was assessed in breast cancer cells derived from primary sites (HCC1395 and HCC1937) and metastatic sites (MCF-7 and MDA-MB-231) by reverse transcriptase-polymerase chain reaction and immunoblotting. We analyzed these proteins' expression in tissue samples from normal breast tissue, usual ductal hyperplasia (DH), atypical ductal hyperplasia (ADH), ductal carcinoma in situ (DCIS), and invasive ductal carcinoma (IDC) using immunohistochemistry. CAIX mRNA was expressed constitutively in MDA-MB-231 cells but not in the other three cell lines. CAIX mRNA expression was increased after CoCl(2)-induced hypoxia in all four breast cancer cell lines. The expression of HIF-1alpha and GLUT1 proteins was increased after CoCl(2)-induced hypoxia in all breast cancer cell lines tested. Hypoxia significantly increased CAIX protein expression in primary cancer cells but not in metastatic ones. HIF-1alpha was not expressed in benign breast tissue, whereas it was significantly expressed in DH, ADH, DCIS, and IDC (p < 0.001). GLUT1 and CAIX were expressed only in DCIS (56.8% and 25.0%) and IDC (44.1% and 30.5%), with higher expression in high grade DCIS than low/intermediate grade DCIS (79.2% vs. 30.0%, p = 0.001 and 37.5% vs. 10.0%, p = 0.036, respectively). High CAIX expression was significantly associated with poor histological grade of IDC (p = 0.005). During breast carcinogenesis, the role of HIF-1alpha changes from response to proliferation to tumor progression. GLUT1 expression (glycolytic phenotype) and CAIX expression (acid-resistant phenotype) may result in a powerful adaptive advantage and represent an aggressive phenotype.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20526721     DOI: 10.1007/s00428-010-0938-0

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  35 in total

1.  Clastogenicity of low pH to various cultured mammalian cells.

Authors:  T Morita; T Nagaki; I Fukuda; K Okumura
Journal:  Mutat Res       Date:  1992-08       Impact factor: 2.433

2.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

Review 3.  Consensus Conference on the classification of ductal carcinoma in situ. The Consensus Conference Committee.

Authors: 
Journal:  Cancer       Date:  1997-11-01       Impact factor: 6.860

4.  Regulation of brain glucose transporters by glucose and oxygen deprivation.

Authors:  B A Bruckner; C V Ammini; M P Otal; M K Raizada; P W Stacpoole
Journal:  Metabolism       Date:  1999-04       Impact factor: 8.694

5.  An acidic environment leads to p53 dependent induction of apoptosis in human adenoma and carcinoma cell lines: implications for clonal selection during colorectal carcinogenesis.

Authors:  A C Williams; T J Collard; C Paraskeva
Journal:  Oncogene       Date:  1999-05-27       Impact factor: 9.867

6.  Cobalt chloride-induced hypoxia modulates the invasive potential and matrix metalloproteinases of primary and metastatic breast cancer cells.

Authors:  Ou-Yang Fu; Ming-Feng Hou; Sheau-Fang Yang; Soon-Cen Huang; Wen-Ying Lee
Journal:  Anticancer Res       Date:  2009-08       Impact factor: 2.480

7.  Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma.

Authors:  S K Chia; C C Wykoff; P H Watson; C Han; R D Leek; J Pastorek; K C Gatter; P Ratcliffe; A L Harris
Journal:  J Clin Oncol       Date:  2001-08-15       Impact factor: 44.544

8.  Differential prognostic impact of hypoxia induced and diffuse HIF-1alpha expression in invasive breast cancer.

Authors:  M M Vleugel; A E Greijer; A Shvarts; P van der Groep; M van Berkel; Y Aarbodem; H van Tinteren; A L Harris; P J van Diest; E van der Wall
Journal:  J Clin Pathol       Date:  2005-02       Impact factor: 3.411

9.  Reduced expression of hypoxia-inducible factor-1alpha in perinecrotic regions of solid tumors.

Authors:  Solmaz Sobhanifar; Christina Aquino-Parsons; Eric J Stanbridge; Peggy Olive
Journal:  Cancer Res       Date:  2005-08-15       Impact factor: 12.701

10.  An evolutionary model of carcinogenesis.

Authors:  Robert A Gatenby; Thomas L Vincent
Journal:  Cancer Res       Date:  2003-10-01       Impact factor: 12.701

View more
  34 in total

1.  Dithiocarbamates strongly inhibit carbonic anhydrases and show antiglaucoma action in vivo.

Authors:  Fabrizio Carta; Mayank Aggarwal; Alfonso Maresca; Andrea Scozzafava; Robert McKenna; Emanuela Masini; Claudiu T Supuran
Journal:  J Med Chem       Date:  2012-02-13       Impact factor: 7.446

2.  Depletion of carbonic anhydrase IX abrogates hypoxia-induced overexpression of stanniocalcin-1 in triple negative breast cancer cells.

Authors:  Elīna Zandberga; Pawel Zayakin; Artūrs Ābols; Dārta Pūpola; Pēteris Trapencieris; Aija Linē
Journal:  Cancer Biol Ther       Date:  2017-06-30       Impact factor: 4.742

3.  Lysyl oxidase is associated with the epithelial-mesenchymal transition of gastric cancer cells in hypoxia.

Authors:  Hiroaki Kasashima; Masakazu Yashiro; Haruhito Kinoshita; Tatsunari Fukuoka; Tamami Morisaki; Go Masuda; Katsunobu Sakurai; Naoshi Kubo; Masaichi Ohira; Kosei Hirakawa
Journal:  Gastric Cancer       Date:  2015-06-23       Impact factor: 7.370

4.  CAIX forms a transport metabolon with monocarboxylate transporters in human breast cancer cells.

Authors:  Samantha Ames; Jacob T Andring; Robert McKenna; Holger M Becker
Journal:  Oncogene       Date:  2019-11-13       Impact factor: 9.867

5.  Analysis of expression of membrane-bound tumor markers in ductal carcinoma in situ of the breast: paving the way for molecular imaging.

Authors:  Jeroen F Vermeulen; Elsken van der Wall; Arjen J Witkamp; Paul J van Diest
Journal:  Cell Oncol (Dordr)       Date:  2013-06-07       Impact factor: 6.730

6.  The role of tumor hypoxia in MUC1-positive breast carcinomas.

Authors:  Juliana Silva Zanetti; Danilo Fiqueredo Soave; João Paulo Oliveira-Costa; Giórgia Gobbi da Silveira; Leandra Náira Zambelli Ramalho; Sérgio Britto Garcia; Sérgio Zucoloto; Alfredo Ribeiro-Silva
Journal:  Virchows Arch       Date:  2011-09-03       Impact factor: 4.064

7.  Overexpression of HIF1α and CAXI predicts poor outcome in early-stage triple negative breast cancer.

Authors:  Min-Sun Jin; Hyebin Lee; In Ae Park; Yul Ri Chung; Seock-Ah Im; Kyung-Hun Lee; Hyeong-Gon Moon; Wonshik Han; Kyubo Kim; Tae-Yong Kim; Dong-Young Noh; Han Suk Ryu
Journal:  Virchows Arch       Date:  2016-05-16       Impact factor: 4.064

8.  The expression of metabolism-related proteins in phyllodes tumors.

Authors:  Ji Eun Kwon; Woo-Hee Jung; Ja Seung Koo
Journal:  Tumour Biol       Date:  2012-09-18

9.  Retinoic acid aliphatic amide inhibits the AMPK-HIF-1α pathway in human ovarian cancer.

Authors:  Xiao-Lan Yu; Ji-Yi Xia; Hai-Qiong Ye; Xia Li; Yu-Jiao Zhang; Xi-Guang Mao
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

10.  Autophagy in breast cancer and its implications for therapy.

Authors:  Kirti Jain; Krishna S Paranandi; Savitha Sridharan; Alakananda Basu
Journal:  Am J Cancer Res       Date:  2013-06-20       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.